قالب وردپرس درنا توس
Home / Business / Dow Jones corrected early losses with Nasdaq leading; these three growth stocks soared

Dow Jones corrected early losses with Nasdaq leading; these three growth stocks soared



On Tuesday afternoon, the Nasdaq index rose, the Dow Jones Industrial Average eliminated most of the previous 89-point drop, and the stock market was mixed.




X



The Nasdaq Index rose 0.5%, the Standard & Poor’s 500 Index rose 0.2%, and the Dow Jones Industrial Average fell less than 0.1% today. Small stocks tracked by Russell in 2000 rose 0.4%. The trading volume on the New York Stock Exchange and the Nasdaq exchange was lower than Monday’s trading volume.

Technology stocks pushed the Nasdaq Composite Index to 43.6% in 2020, the fifth best year ever. The S&P 500 index rose 16.3%, and the Dow rose 7.2%. After a strong start to the year, the market has now rebounded from a brief correction. Read The Big Picture for detailed daily market analysis.

The Covid-19 pandemic has already collapsed the U.S. economy because the nationwide lock-up period has exceeded one year. But many states are easing restrictions. With the introduction of vaccines and cases in some states begin to stabilize, there are signs of hope.

U.S. stock market overview today

index Symbol price Gain/loss % Change
Dow Jones (0DJIA) 33510.06 -17.13 -0.05
S&P 500 (0S&P5) 4085.25 +7.34 +0.18
Nasdaq (0NDQC) 13,769.24 +63.65 +0.46
Russell 2000 (ETC.) 225.78 +0.81 +0.36
IBD 50 (FFTY) 45.45 +0.44 +0.98
Last update: 4/6/2021 12:00 PM Eastern Time

According to Worldometer’s data, the cumulative number of Covid-19 cases worldwide is close to 133 million, and the death toll is close to 2.9 million. In the United States, despite the sharp decline in the number of new cases, there have been more than 31.5 million cases and 569,000 deaths.

Dow Jones index winners and losers

Nike (OF) and Coca Cola (KO) all increased by more than 1%.

Nike rose 1.5% and is about to resume its 50-day moving average. According to MarketSmith’s chart analysis, the stock price has been consolidating at a buying price of 138.05 in the past 15 weeks. Nike’s stock is about 7% away from the admission ticket.

Last week, Nike won a lawsuit accusing MSCHF Product Studio of infringing on the shoe giant’s trademark in cooperation with rapper Lil Nas X’s “Satan Shoes”.

Coca-Cola rose 1.2% and is shaping the cup shape at a purchase price of 55.03. It is about 3% lower than the entry. The overall rating of Coca-Cola stock is 34, which is well below the 90 minimum requirement for leading stocks. Part of the overall strength score, the relative strength rating is 25, which means it lags 75% of all other stocks.

Walgreens Boots League (WBA), Boeing (BA) and United Health (UNH) is the largest blue chip decliner, each falling more than 1%.

Microsoft (MSFT) fell slightly by 0.1%, but was still in the buying range after breaking through the buying point of 246.23 on Monday. The highest purchase price of Microsoft stock is 258.54. The software giant is the IBD ranking and IBD long-term leader stock.

Beyond Dow Jones

Among IBD’s 197 industry organizations, solar, oil and gas, and apparel stocks led the gains. Steel, software and telecommunications stocks lagged.

IBD 50 inventory Green Brick Partners (GRBK) surged 10% in heavy trading, reaching its highest level in 10 years. The stock broke through the 25.15 buy point at the bottom of the 20-week cup. Now start to expand from the entry, the purchase range is up to 26.78. This Texas-based homebuilder traded at about 27.10 at midday. Green Brick is one of the stocks of IBD’s daily selection on Monday.

Under the leadership of Green Brick, the Innovator IBD 50 ETF (FFTY) rose by 1%, Pinterest (PINS) and snowman (YETI).

New problem GreenBox POS (GBOX) surged 18%, extending Monday’s breakout to 15.45 purchase points at the bottom of the six-week cup. Now, you can share stocks well from the entry. The processing volume of payment companies based on blockchain ledger is estimated to have doubled this year to at least $1.2 billion. GreenBox went on sale on February 18.

Illuminance (ILMN) is about to recover its 50-day trading volume, so its rapid turnover increased by 9%. On Monday evening, the manufacturer of genetic analysis systems said that it expects revenue in the first quarter to exceed $1 billion. It also predicts that full-year revenue will grow by 25% to 28%, well above Wall Street’s 17% growth target.

Follow Nancy Gondo on Twitter via @IBD_NGondo

You may also like:

Popular stocks to buy or watch with the launch of Covid cases

Use IBD 50 to find today’s most noteworthy growth stocks

Learn how to use IBD’s ETF market strategy to time the market

Use the IBD leaderboard to view the stocks on the market leader list




Source link